These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11464874)

  • 1. Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
    Yoneda A; Oue T; Imura K; Inoue M; Yagi K; Kawa K; Nishikawa M; Morimoto S; Nakayama M
    Med Pediatr Oncol; 2001 Jan; 36(1):160-2. PubMed ID: 11464874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profile of neuroblastoma detected by mass screening, resected after observation without treatment: results of the Wait and See pilot study.
    Oue T; Inoue M; Yoneda A; Kubota A; Okuyama H; Kawahara H; Nishikawa M; Nakayama M; Kawa K
    J Pediatr Surg; 2005 Feb; 40(2):359-63. PubMed ID: 15750929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
    Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
    Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening.
    Tanaka M; Kigasawa H; Kato K; Ijiri R; Nishihira H; Aida N; Ohama Y; Tanaka Y
    Pediatr Blood Cancer; 2010 Apr; 54(4):573-8. PubMed ID: 20049932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial to discriminate spontaneous regression from non-regression cases during mass screening for neuroblastoma.
    Nishi M; Miyake H; Takeda T; Yonemori H; Hanai J; Kikuchi Y; Takasugi N
    Jpn J Clin Oncol; 1994 Oct; 24(5):247-51. PubMed ID: 7967103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results for 79 patients with neuroblastoma detected through mass screening at 6 months of age in a single institute.
    Nishio N; Mimaya J; Nara T; Takashima Y; Horikoshi Y; Urushihara N; Hasegawa S; Aoki K; Hamasaki M
    Pediatr Int; 2006 Dec; 48(6):531-5. PubMed ID: 17168969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ultrasound in managing neuroblastoma detected by mass screening: a proposed ultrasonographic grading for children with neuroblastoma.
    Hirata T; Tatara H; Zaizen Y; Suita S; Matsuzaki A; Ueda K
    J Clin Ultrasound; 1995 Jun; 23(5):305-13. PubMed ID: 7642769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroperitoneal ganglioneuroblastoma resected 8 years after mass screening: a case report.
    Nakaoka T; Uemura S; Nakagawa Y; Yano T; Oda M
    J Pediatr Surg; 2007 Nov; 42(11):E29-32. PubMed ID: 18022424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up results of the observation program for neuroblastoma detected at 6-month mass screening.
    Arakawa A; Oguma E; Aihara T; Kishimoto H; Kikuchi A; Hanada R; Koh K
    J Pediatr; 2014 Oct; 165(4):855-7.e1. PubMed ID: 25091258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass screening of neuroblastoma in Sapporo City, Japan.
    Nishi M; Miyake H; Takeda T; Kikuchi Y; Hanai J; Yonemori H; Takasugi N
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):327-31. PubMed ID: 1456398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connatal localized neuroblastoma. The case to delay treatment.
    Kerbl R; Urban CE; Lackner H; Höfler G; Ambros IM; Ratschek M; Ambros PF
    Cancer; 1996 Apr; 77(7):1395-401. PubMed ID: 8608521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stephen L. Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions.
    Suita S
    J Pediatr Surg; 2002 Jul; 37(7):949-54. PubMed ID: 12077747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
    Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological aspects of neuroblastomas identified by mass screening in Quebec.
    Brodeur GM; Look AT; Shimada H; Hamilton VM; Maris JM; Hann HW; Leclerc JM; Bernstein M; Brisson LC; Brossard J; Lemieux B; Tuchman M; Woods WG
    Med Pediatr Oncol; 2001 Jan; 36(1):157-9. PubMed ID: 11464873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mass screening for neuroblastoma and the presumptive natural history of this tumor.
    Takeda T; Shimada M; Iizuka S; Takasugi N
    Prog Clin Biol Res; 1994; 385():383-8. PubMed ID: 7972235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma: epidemiology and pattern of regression. Problems in interpreting results of mass screening.
    Carlsen NL
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):103-10. PubMed ID: 1530115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Past and future of neuroblastoma screening in Japan.
    Sawada T
    Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):320-6. PubMed ID: 1456397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.